Interim proposal for collecting and handling of microbiology specimens from patients with COVID‐19 in general hospitals  

作　　者：Zhaofang Jiang Shan Chen Jiayao Qu Siyuan Liu Tao Hong Houming Liu Yi‐Wei Tang Jiuxin Qu Hongzhou Lu 

机构地区：[1]Department of Clinical Laboratory,Shenzhen Third People's Hospital,Southern University of Science and Technology,National Clinical Research Center for Infectious Diseases,Shenzhen,Guangdong,China [2]Department of Medical Affairs,Danaher/Cepheid China,Shanghai,China [3]Department of Pathology,Rhode Island Hospital,Providence,Rhode Island,USA

出　　处：《iLABMED》2023年第1期15-21,共7页智能检验医学（英文）

基　　金：Special Support Fund of Shenzhen for Introduced High‐Level Medical Team,Grant/Award Number:SZSM201412005;Guangdong Basic and Applied Basic Research Foundation,Grant/Award Number:2020A1515010586;Science and Technology program of Shenzhen,Grant/Award Number:JCYJ20190809144005609。

摘　　要：1|INTRODUCTION Accurate pathogenic testing is essential for early diag-nosis and precise treatment of COVID‐19,and correct specimen collection and handling is vital for accurate diagnosis[1].With the continuing mutations,the pathogenicity of Severe acute respiratory syndrome coronavirus 2(SARS‐CoV‐2)has gradually decreased,so the management of COVID‐19 in China has been down-graded to Class B(http://www.nhc.gov.cn).Infections with different SARS‐CoV‐2 variants produce variable clinical manifestations,and the types of specimens vary accordingly[2].The purpose of developing this guideline was to standardize the process of specimen collection and handling for microbiological testing from patients with confirmed or suspected COVID‐19 to avoid incorrect diagnosis and treatment.

关 键 词：KEYWORDS biosafety COVID‐19 microbiology specimens SARS‐CoV‐2 

分 类 号：R51[医药卫生—内科学]